Moberg Pharma AB (MBGPF)
1.10
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Moberg Pharma Gross Profit Margin (Quarterly) : 66.17% for March 31, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 66.17% |
| December 31, 2025 | 48.36% |
| September 30, 2025 | 60.38% |
| June 30, 2025 | 47.20% |
| March 31, 2025 | 66.29% |
| December 31, 2024 | -13.43% |
| September 30, 2024 | 84.05% |
| June 30, 2024 | 66.21% |
| March 31, 2024 | 19.90% |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | -212.2% |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 |
| Date | Value |
|---|---|
| June 30, 2019 | |
| March 31, 2019 | 95.92% |
| December 31, 2018 | 65.58% |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 61.97% |
| September 30, 2017 | 62.36% |
| June 30, 2017 | 65.44% |
| March 31, 2017 | 60.33% |
| December 31, 2016 | 62.48% |
| September 30, 2016 | 63.70% |
| June 30, 2016 | 68.83% |
| March 31, 2016 | 66.13% |
| December 31, 2015 | 62.89% |
| September 30, 2015 | 68.73% |
| June 30, 2015 | 74.49% |
| March 31, 2015 | 74.18% |
| December 31, 2014 | 68.28% |
| September 30, 2014 | 68.02% |
| June 30, 2014 | 74.03% |
| March 31, 2014 | 75.58% |
| December 31, 2013 | 69.88% |
| September 30, 2013 | 70.84% |
| June 30, 2013 | 79.03% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Orexo AB | -86.00% |
| Swedencare AB | 7.60% |
| Camurus AB | 91.74% |
| Infant Bacterial Therapeutics AB | -- |
| AstraZeneca PLC | 76.09% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -3.84% |
| Return on Assets | -3.73% |
| Return on Invested Capital | -3.82% |
| Profit Margin (Quarterly) | -25.66% |
| Operating Margin (Quarterly) | -88.95% |
| Return on Net Operating Assets | -7.26% |